Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Theobromine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Theobromine?

Theobromine is an investigational drug.

There have been 4 clinical trials for Theobromine. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2015.

The most common disease conditions in clinical trials are Bronchitis, Paralysis, and Diverticulitis. The leading clinical trial sponsors are Ahn-Gook Pharmaceuticals Co.,Ltd, Thomas Steffen, and Gottfried und Julia Bangerter-Rhyner Foundation, Switzerland.

There is one US patent protecting this investigational drug and seventeen international patents.

Recent Clinical Trials for Theobromine
Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?Gottfried und Julia Bangerter-Rhyner Foundation, SwitzerlandN/A
Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?Thomas SteffenN/A
Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic SubjectsCanadian Institutes of Health Research (CIHR)Phase 4

See all Theobromine clinical trials

Clinical Trial Summary for Theobromine

Top disease conditions for Theobromine
Top clinical trial sponsors for Theobromine

See all Theobromine clinical trials

US Patents for Theobromine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Theobromine   Start Trial Antidiabetic tricyclic compounds Merck Sharp & Dohme (Rahway, NJ)   Start Trial
Theobromine   Start Trial Antiviral drugs for treatment of arenavirus infection Kineta Viral Hemorrhagic Fever, LLC (Seattle, WA)   Start Trial
Theobromine   Start Trial Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers eFFECTOR Therapeutics, Inc. (San Diego, CA)   Start Trial
Theobromine   Start Trial Methyl diazepane orexin receptor antagonists Merck Sharp & Dohme Corp. (Rahway, NJ)   Start Trial
Theobromine   Start Trial Inhibitors of HIF prolyl hydroxylase Merck Sharp & Dohme Corp. (Rahway, NJ)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Theobromine

Drugname Country Document Number Estimated Expiration Related US Patent
Theobromine Australia 2015263620 2034-05-22   Start Trial
Theobromine Canada 2947781 2034-05-22   Start Trial
Theobromine China 106458913 2034-05-22   Start Trial
Theobromine European Patent Office 3145915 2034-05-22   Start Trial
Theobromine Japan 2017516771 2034-05-22   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.